CIK: 0001609251 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 15, 2022
Total Value ($000): $314,064 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 184,648 | $49,301 | 15.7% | $267.94 | -20.7% | COM | 09062X103 |
| UTHR | UNITED THERAPEUTICS CORP | 200,407 | $41,961 | 13.4% | $121.76 | +83.6% | COM | 91307C102 |
| REGN | REGENERON PHARMACEUTICALS | 60,889 | $41,945 | 13.4% | $342.96 | +82.5% | COM | 75886F107 |
| ALKS | ALKERMES PLC | 1,411,682 | $31,523 | 10.0% | $18.73 | +38.8% | COM | G01767105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 589,360 | $30,570 | 9.7% | $45.84 | +27.5% | COM | 29251M106 |
| EMBC | EMBECTA CORP | 1,024,200 | $29,487 | 9.4% | $25.42 | +2.9% | COM | 29082K105 |
| EXEL | EXELIXIS INC | 1,821,475 | $28,561 | 9.1% | $18.87 | +2.4% | COM | 30161Q104 |
| CAH | CARDINAL HEALTH INC | 336,742 | $22,454 | 7.1% | $55.61 | +6.6% | COM | 14149Y108 |
| — | TARO PHARMACEUTICAL INDUS | 580,793 | $17,412 | 5.5% | $75.44 | — | COM | M8737E108 |
| MCK | MCKESSON CORP | 31,913 | $10,846 | 3.5% | $138.18 | +147.0% | COM | 58155Q103 |
| KOD | KODIAK SCIENCES INC | 469,388 | $3,633 | 1.2% | $33.04 | -70.6% | COM | 50015M109 |
| EGRX | EAGLE PHARMACEUTICALS INC | 121,083 | $3,199 | 1.0% | $44.36 | -17.3% | COM | 269796108 |
| VNDA | VANDA PHARMACEUTICALS INC | 312,299 | $3,086 | 1.0% | $10.56 | 0.0% | COM | 921659108 |
| — | NEXTCURE INC | 31,298 | $86 | 0.0% | $9.88 | — | COM | 65343E108 |